HO-3867 mediated modulation of Extracellular vesicles and Tumor microenvironment: A novel immunotherapeutic strategy for ovarian cancer
Ganesh Yadagiri, Lakshmi Narasimhan Chakrapani, Shyam Sundaram, Jessica Velasquez, Tiffany L. Hughes, Gabriela S. Vendrell, Balázs Bognár, Qi‐En Wang, David M. O’Malley, David E. Cohn, Karuppaiyah Selvendiran, Kalpana Deepa Priya Dorayappan
This study shows that HO-3867 and bevacizumab together reduce ascites, limit tumor spread, and enhance anti-tumor immunity in ovarian cancer models by modulating extracellular vesicles and immune cells.
bioRxiv · May 16, 2025 · PreprintCancer Biology